Halios, Neneta B.

HRN: 08-50-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2026
07/27/2026
IV
2.25g
Q6
Urosepsis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: